BRAF and melanoma: Reasons for longer TTNT in SRT patients are many fold and include incomplete staging, which might be postponed until after SRT (e.g. due to conflicting appointments), side effects, undesirable combination with planned systemic therapy (e.g. BRAF and MEK inhibitors in melanoma patients), patient refusal to undergo parallel treatments [20].